Impact Biomedical has announced that it is correcting the exchange ratio for its pending merger.
The company also disclosed that it will implement a reverse stock split, though further details were not immediately available.


Impact Biomedical announced a correction to its merger exchange ratio and a reverse stock split.

Impact Biomedical has announced that it is correcting the exchange ratio for its pending merger.
The company also disclosed that it will implement a reverse stock split, though further details were not immediately available.

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
Mehr von Priya Anand →

